Home › Multiple Myeloma › North Dakota › Fargo
Multiple Myeloma clinical trials in Fargo, ND
4 studies for Multiple Myeloma are looking for participants at sites in and around Fargo (within about 30 miles). Open a study to see who can join and how to contact the study team.
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RecruitingPhase 2
- Sanford Health- Fargo, Fargo
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
RecruitingPhase 3
- Sanford Fargo Medical Center, Fargo
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Essentia Health, Fargo
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
RecruitingPhase 3
- Essentia Health Cancer Center-South University Clinic, Fargo
- Sanford South University Medical Center, Fargo
- Southpointe-Sanford Medical Center Fargo, Fargo
- and 3 more
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO26 studies
- Columbus, OH24 studies
- Rochester, MN24 studies
- Baldwin Park, CA23 studies
- St. Louis, MO23 studies
- Chicago, IL22 studies
Other studies in Fargo
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer13 studies
- Cancer (all types)11 studies
- Melanoma9 studies
- Obesity9 studies
- Prostate Cancer8 studies
- Overweight8 studies
- Breast Cancer7 studies
- Colorectal Cancer7 studies
- Pancreatic Cancer6 studies
- Type 2 Diabetes6 studies
- Colon Cancer6 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.